Stocchi F - Search Results

1

Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.

Espay AJ, Stocchi F, Pahwa R, Albanese A, Ellenbogen A, Ferreira JJ, Giladi N, Gurevich T, Hassin-Baer S, Hernandez-Vara J, Isaacson SH, Kieburtz K, LeWitt PA, Lopez-Manzanares L, Olanow CW, Poewe W, Sarva H, Yardeni T, Adar L, Salin L, Lopes N, Sasson N, Case R, Rascol O; BouNDless Study Group. Espay AJ, et al. Among authors: stocchi f. Lancet Neurol. 2024 May;23(5):465-476. doi: 10.1016/S1474-4422(24)00052-8. Epub 2024 Mar 15. Lancet Neurol. 2024. PMID: 38499015 Clinical Trial.

2

Motor fluctuations in levodopa treatment: clinical pharmacology.

Stocchi F, Bonamartini A, Vacca L, Ruggieri S. Stocchi F, et al. Eur Neurol. 1996;36 Suppl 1:38-42. doi: 10.1159/000118882. Eur Neurol. 1996. PMID: 8791020 Review.

3

Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease.

Ruggieri S, De Pandis MF, Bonamartini A, Vacca L, Stocchi F. Ruggieri S, et al. Among authors: stocchi f. Clin Neuropharmacol. 1997 Jun;20(3):204-9. doi: 10.1097/00002826-199706000-00003. Clin Neuropharmacol. 1997. PMID: 9197942

4

Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group.

Rascol O, Brooks DJ, Brunt ER, Korczyn AD, Poewe WH, Stocchi F. Rascol O, et al. Among authors: stocchi f. Mov Disord. 1998 Jan;13(1):39-45. doi: 10.1002/mds.870130111. Mov Disord. 1998. PMID: 9452324 Clinical Trial.

5

Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.

Korczyn AD, Brooks DJ, Brunt ER, Poewe WH, Rascol O, Stocchi F. Korczyn AD, et al. Among authors: stocchi f. Mov Disord. 1998 Jan;13(1):46-51. doi: 10.1002/mds.870130112. Mov Disord. 1998. PMID: 9452325 Clinical Trial.

6

The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease.

Schrag AE, Brooks DJ, Brunt E, Fuell D, Korczyn A, Poewe W, Quinn NP, Rascol O, Stocchi F. Schrag AE, et al. Among authors: stocchi f. Clin Neuropharmacol. 1998 May-Jun;21(3):169-75. Clin Neuropharmacol. 1998. PMID: 9617508 Clinical Trial.

7

Urinary and anorectal function evaluation in Parkinson's disease.

Stocchi F, Corazziari E, Carbone A, Vacca L, De Pandis MF, Berardelli A, Ruggieri SA. Stocchi F, et al. Adv Neurol. 1999;80:347-51. Adv Neurol. 1999. PMID: 10410740 No abstract available.

8

Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms.

Vanacore N, Bonifati V, Fabbrini G, Colosimo C, Marconi R, Nicholl D, Bonuccelli U, Stocchi F, Lamberti P, Volpe G, De Michele G, Iavarone I, Bennett P, Vieregge P, Meco G. Vanacore N, et al. Among authors: stocchi f. Neurology. 2000 Jan 11;54(1):114-9. doi: 10.1212/wnl.54.1.114. Neurology. 2000. PMID: 10636135

9

Why delaying levodopa is a good treatment strategy in early Parkinson's disease.

Olanow CW, Stocchi F. Olanow CW, et al. Among authors: stocchi f. Eur J Neurol. 2000 May;7 Suppl 1:3-8. Eur J Neurol. 2000. PMID: 11054152 Review. No abstract available.

10

Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results.

Stocchi F, Vacca L, De Pandis MF, Barbato L, Valente M, Ruggieri S. Stocchi F, et al. Neurol Sci. 2001 Feb;22(1):93-4. doi: 10.1007/s100720170062. Neurol Sci. 2001. PMID: 11487217 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters